Fingerprint
Dive into the research topics of 'Randomized phase II study of bortezomib alone and bortezomib in combination with docetaxel in previously treated advanced non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically